Jeffrey E. Russel

Array ( [id] => 3949473 [patent_doc_number] => 05977310 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Peg-modified HGF' [patent_app_type] => 1 [patent_app_number] => 8/913236 [patent_app_country] => US [patent_app_date] => 1997-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6122 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977310.pdf [firstpage_image] =>[orig_patent_app_number] => 913236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4137323 [patent_doc_number] => 06015787 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-18 [patent_title] => 'Cell-permeable protein inhibitors of calpain' [patent_app_type] => 1 [patent_app_number] => 8/964302 [patent_app_country] => US [patent_app_date] => 1997-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 7785 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/015/06015787.pdf [firstpage_image] =>[orig_patent_app_number] => 964302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4188584 [patent_doc_number] => 06093797 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-25 [patent_title] => 'Tri-, Tetra-, Penta-, and polypeptides and their therapeutic use as an antidepressant agent' [patent_app_type] => 1 [patent_app_number] => 8/962962 [patent_app_country] => US [patent_app_date] => 1997-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 41383 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/093/06093797.pdf [firstpage_image] =>[orig_patent_app_number] => 962962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4137288 [patent_doc_number] => 06015785 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-18 [patent_title] => 'Aglucone isofavone enriched vegetable protein extract and isolate and process for producing' [patent_app_type] => 1 [patent_app_number] => 8/961829 [patent_app_country] => US [patent_app_date] => 1997-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3887 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/015/06015785.pdf [firstpage_image] =>[orig_patent_app_number] => 961829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1285654 [patent_doc_number] => 06638909 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-28 [patent_title] => 'Wound healing compositions containing alpha-1-antitrypsin' [patent_app_type] => B1 [patent_app_number] => 08/957654 [patent_app_country] => US [patent_app_date] => 1997-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 1644 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/638/06638909.pdf [firstpage_image] =>[orig_patent_app_number] => 08957654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446805 [patent_doc_number] => 06369033 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein' [patent_app_type] => B1 [patent_app_number] => 08/953937 [patent_app_country] => US [patent_app_date] => 1997-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 7600 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/369/06369033.pdf [firstpage_image] =>[orig_patent_app_number] => 08953937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3979474 [patent_doc_number] => 05948750 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-07 [patent_title] => 'Conjugates useful in the treatment of prostate cancer' [patent_app_type] => 1 [patent_app_number] => 8/950805 [patent_app_country] => US [patent_app_date] => 1997-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19334 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/948/05948750.pdf [firstpage_image] =>[orig_patent_app_number] => 950805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4016908 [patent_doc_number] => 05906828 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-25 [patent_title] => 'Cell growth substrates with tethered cell growth effector molecules' [patent_app_type] => 1 [patent_app_number] => 8/947063 [patent_app_country] => US [patent_app_date] => 1997-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 7415 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/906/05906828.pdf [firstpage_image] =>[orig_patent_app_number] => 947063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4179283 [patent_doc_number] => 06037323 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders' [patent_app_type] => 1 [patent_app_number] => 8/940093 [patent_app_country] => US [patent_app_date] => 1997-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 22 [patent_no_of_words] => 53843 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 481 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037323.pdf [firstpage_image] =>[orig_patent_app_number] => 940093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4192592 [patent_doc_number] => 06043219 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-28 [patent_title] => 'Broad spectrum chemotherapeutic peptide' [patent_app_type] => 1 [patent_app_number] => 8/931999 [patent_app_country] => US [patent_app_date] => 1997-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 6711 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/043/06043219.pdf [firstpage_image] =>[orig_patent_app_number] => 931999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3986381 [patent_doc_number] => 05985242 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Modulators of .beta.-amyloid peptide aggregation comprising D-amino acids' [patent_app_type] => 1 [patent_app_number] => 8/920162 [patent_app_country] => US [patent_app_date] => 1997-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 27613 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985242.pdf [firstpage_image] =>[orig_patent_app_number] => 920162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4186785 [patent_doc_number] => 06042848 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-28 [patent_title] => 'Enhancement of antimicrobial peptide activity by metal ions' [patent_app_type] => 1 [patent_app_number] => 8/911794 [patent_app_country] => US [patent_app_date] => 1997-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3951 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/042/06042848.pdf [firstpage_image] =>[orig_patent_app_number] => 911794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4057902 [patent_doc_number] => 05863890 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-26 [patent_title] => 'Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality' [patent_app_type] => 1 [patent_app_number] => 8/907217 [patent_app_country] => US [patent_app_date] => 1997-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 50 [patent_no_of_words] => 15819 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/863/05863890.pdf [firstpage_image] =>[orig_patent_app_number] => 907217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4262488 [patent_doc_number] => 06306440 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Therapeutic preparation for inhalation' [patent_app_type] => 1 [patent_app_number] => 8/906825 [patent_app_country] => US [patent_app_date] => 1997-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 7078 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306440.pdf [firstpage_image] =>[orig_patent_app_number] => 906825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4157437 [patent_doc_number] => 06156726 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Voltage-gated calcium channel antagonist and method' [patent_app_type] => 1 [patent_app_number] => 8/904431 [patent_app_country] => US [patent_app_date] => 1997-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 29 [patent_no_of_words] => 24393 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156726.pdf [firstpage_image] =>[orig_patent_app_number] => 904431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4216092 [patent_doc_number] => 06110892 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Parathyroid hormone analogues for the treatment of osteoporosis' [patent_app_type] => 1 [patent_app_number] => 8/904760 [patent_app_country] => US [patent_app_date] => 1997-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 28 [patent_no_of_words] => 13028 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110892.pdf [firstpage_image] =>[orig_patent_app_number] => 904760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4002484 [patent_doc_number] => 05858965 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Pharmaceutical compositions for the treatment of autoimmune diseases comprising the B-oligomer of pertussis toxin or its subunits' [patent_app_type] => 1 [patent_app_number] => 8/849376 [patent_app_country] => US [patent_app_date] => 1997-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 4319 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858965.pdf [firstpage_image] =>[orig_patent_app_number] => 849376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1256694 [patent_doc_number] => 06667389 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-23 [patent_title] => 'Technetium-99m labeled peptides for imaging' [patent_app_type] => B1 [patent_app_number] => 08/889212 [patent_app_country] => US [patent_app_date] => 1997-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6633 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/667/06667389.pdf [firstpage_image] =>[orig_patent_app_number] => 08889212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1573881 [patent_doc_number] => 06468549 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Acidic compositions or dermatological composition containing a crosslinked poly (2-acrylamido-2-methylpropanesulfonic acid) neutralized to at least 90% ' [patent_app_type] => B1 [patent_app_number] => 08/885167 [patent_app_country] => US [patent_app_date] => 1997-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5390 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/468/06468549.pdf [firstpage_image] =>[orig_patent_app_number] => 08885167 [rel_patent_id] =>[rel_patent_doc_number] =>)